Filing Details

Accession Number:
0001179110-13-007681
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-05-03 16:37:48
Reporting Period:
2013-05-01
Filing Date:
2013-05-03
Accepted Time:
2013-05-03 16:37:48
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1012140 Onyx Pharmaceuticals Inc ONXX Biological Products, (No Disgnostic Substances) (2836) 943154463
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1227124 Paul Goddard C/O Onyx Pharmaceuticals, Inc.
249 E. Grand Ave.
South San Francisco CA 94080
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-05-01 4,000 $12.50 18,890 No 4 M Direct
Common Stock Acquisiton 2013-05-01 1,000 $28.41 19,890 No 4 M Direct
Common Stock Disposition 2013-05-01 3,000 $92.67 16,890 No 4 S Direct
Common Stock Disposition 2013-05-01 1,000 $93.85 15,890 No 4 S Direct
Common Stock Disposition 2013-05-01 800 $93.02 15,090 No 4 S Direct
Common Stock Disposition 2013-05-01 200 $94.08 14,890 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2013-05-01 4,000 $0.00 4,000 $12.50
Common Stock Stock Option (Right to Buy) Disposition 2013-05-01 1,000 $0.00 1,000 $28.41
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
2,000 2017-02-07 No 4 M Direct
6,000 2015-02-07 No 4 M Direct
Footnotes
  1. Shares sold pursuant to 10b5-1 plan.
  2. The shares were sold at prices ranging from $92.62 to $92.84. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
  3. The shares were sold at prices ranging from $93.61 to $94.08. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
  4. The shares were sold at prices ranging from $92.62to $93.62. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price
  5. Fully vested.